Intra-Cellular Therapies, Inc. Quarterly Common Stock, Shares Authorized from Q3 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Intra-Cellular Therapies, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2012 to Q3 2024.
  • Intra-Cellular Therapies, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 175M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 175M 0 0% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 175M 0 0% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 175M 0 0% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 175M 0 0% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 175M 0 0% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 175M 0 0% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 175M 0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 175M 0 0% Dec 31, 2022 10-K 2024-02-22
Q3 2022 175M 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 175M 0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 175M +75M +75% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 175M +75M +75% Dec 31, 2021 10-K 2023-03-01
Q3 2021 175M +75M +75% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 175M +75M +75% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 100M 0 0% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 100M 0 0% Dec 31, 2020 10-K 2022-03-01
Q3 2020 100M 0 0% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 100M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 100M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 100M 0 0% Dec 31, 2019 10-K 2021-02-25
Q3 2019 100M 0 0% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 100M 0 0% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 100M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 100M 0 0% Dec 31, 2018 10-K 2020-03-02
Q3 2018 100M 0 0% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 100M 0 0% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 100M 0 0% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 100M 0 0% Dec 31, 2017 10-K 2019-02-27
Q3 2017 100M 0 0% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 100M 0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 100M 0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 100M 0 0% Dec 31, 2016 10-K 2018-03-01
Q3 2016 100M 0 0% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 100M 0 0% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 100M 0 0% Mar 31, 2016 10-Q 2016-04-28
Q4 2015 100M 0 0% Dec 31, 2015 10-K 2017-03-01
Q3 2015 100M 0 0% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 100M 0 0% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 100M 0 0% Mar 31, 2015 10-Q 2015-04-30
Q4 2014 100M 0 0% Dec 31, 2014 10-K 2016-02-25
Q3 2014 100M 0 0% Sep 30, 2014 10-Q 2014-11-03
Q2 2014 100M 0 0% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 100M 0 0% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 100M 0 0% Dec 31, 2013 10-K 2015-03-12
Q3 2013 100M 0 0% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 100M Jun 30, 2013 10-Q 2013-08-15
Q1 2013 100M Mar 31, 2013 10-Q 2013-08-15
Q4 2012 100M Dec 31, 2012 10-K 2014-03-25
Q3 2012 100M Aug 29, 2012 10-Q 2013-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.